Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts
Open Access
- 30 June 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 25 (7), 1658-1667
- https://doi.org/10.1002/jbmr.42
Abstract
Postfracture tibial nonunion (pseudoarthrosis) leads to lifelong disability in patients with neurofibromatosis type I (NF1), a disorder caused by mutations in the NF1 gene. To determine the contribution of NF1 in bone healing, we assessed bone healing in the Nf1 conditional mouse model lacking Nf1 specifically in osteoblasts. A closed distal tibia fracture protocol and a longitudinal study design were used. During the 21‐ to 28‐day postfracture period, callus volume, as expected, decreased in wild‐type but not in Nf1 mice, suggesting delayed healing. At these two time points, bone volume (BV/TV) and volumetric bone mineral density (vBMD) measured by 3D micro–computed tomography were decreased in Nf1 callus‐bridging cortices and trabecular compartments compared with wild‐type controls. Histomorphometric analyses revealed the presence of cartilaginous remnants, a high amount of osteoid, and increased osteoclast surfaces in Nf1 calluses 21 days after fracture, which was accompanied by increased expression of osteopontin, Rankl, and Tgfβ. Callus strength measured by three‐point bending 28 days after fracture was reduced in Nf1 versus wild‐type calluses. Importantly, from a clinical point of view, this defect of callus maturation and strength could be ameliorated by local delivery of low‐dose lovastatin microparticles, which successfully decreased osteoid volume and cartilaginous remnant number and increased callus BV/TV and strength in mutant mice. These results thus indicate that the dysfunctions caused by loss of Nf1 in osteoblasts impair callus maturation and weaken callus mechanical properties and suggest that local delivery of low‐dose lovastatin may improve bone healing in NF1 patients. © 2010 American Society for Bone and Mineral ResearchKeywords
This publication has 53 references indexed in Scilit:
- ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiaeCell Metabolism, 2006
- Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1–haploinsufficient osteoclast functionsJCI Insight, 2006
- Distribution of lovastatin to bone and its effect on bone turnover in ratsJournal of Pharmacy and Pharmacology, 2006
- Double Inactivation of NF1 in Tibial PseudarthrosisAmerican Journal of Human Genetics, 2006
- Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysisOsteoporosis International, 2005
- Relation of Statin Use and Bone Loss: A Prospective Population-Based Cohort Study in Early Postmenopausal WomenOsteoporosis International, 2002
- Effect of HMG-CoA Reductase Inhibitors (Statins) on Bone Mineral DensityJournal of Clinical Densitometry, 2002
- NF1 Tumor Suppressor Gene FunctionCell, 2001
- Pathology of Bone Lesions Associated With Congenital Pseudarthrosis of the LegJournal of Pediatric Orthopaedics B, 2000
- Congenital Pseudarthrosis of the Tibia: A Retrospective ReviewJournal of Pediatric Orthopaedics, 1999